The CD83 Molecule – An Important Immune Checkpoint
暂无分享,去创建一个
Y. Muller | A. Steinkasserer | H. Sticht | M. Lechmann | E. Zinser | Ilka Knippertz | Dmytro Royzman | A. Wild | Linda Grosche | C. König
[1] A. Steinkasserer,et al. Quercetin induces an immunoregulatory phenotype in maturing human dendritic cells. , 2020, Immunobiology.
[2] A. Steinkasserer,et al. Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic Cells , 2020, Viruses.
[3] X. Geng,et al. Soluble CD83 alleviates experimental allergic rhinitis through modulating antigen-specific Th2 cell property , 2020, International journal of biological sciences.
[4] T. Winkler,et al. CD83 orchestrates immunity towards self and non-self in dendritic cells. , 2019, JCI insight.
[5] M. Zygmunt,et al. CD83 is locally regulated and differentially expressed in disturbed murine pregnancy. , 2019, Reproduction.
[6] A. Steinkasserer,et al. Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells , 2019, Front. Immunol..
[7] P. Silveira,et al. CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential , 2019, Front. Immunol..
[8] M. Rauh,et al. Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner , 2019, Front. Immunol..
[9] J. Hauber,et al. The acidic protein rich in leucines Anp32b is an immunomodulator of inflammation in mice , 2019, Scientific Reports.
[10] Hongxia Wei,et al. Abnormal Expression of Indoleamine 2, 3-Dioxygenase in Human Recurrent Miscarriage. , 2019, Reproductive sciences.
[11] J. Myśliwska,et al. Putative loss of CD83 immunosuppressive activity in long-standing complication-free juvenile diabetic patients during disease progression , 2019, Immunologic research.
[12] G. Schett,et al. Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis , 2018, Nature Reviews Rheumatology.
[13] Alison S Care,et al. Regulatory T cells in embryo implantation and the immune response to pregnancy , 2018, The Journal of clinical investigation.
[14] Y. Kochi,et al. Reduction of CD83 Expression on B Cells and the Genetic Basis for Rheumatoid Arthritis: Comment on the Article by Thalayasingam et al , 2018, Arthritis & rheumatology.
[15] H. Bi,et al. Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells , 2018, Front. Immunol..
[16] H. Keyvani,et al. The levels of soluble forms of CD21 and CD83 in multiple sclerosis , 2018, Journal of Neuroimmunology.
[17] T. Winkler,et al. CD83 expression is essential for Treg cell differentiation and stability. , 2018, JCI insight.
[18] A. Barton,et al. CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in untreated early arthritis: implications for causal gene identification , 2018 .
[19] A. Barton,et al. CD4+ and B Lymphocyte Expression Quantitative Traits at Rheumatoid Arthritis Risk Loci in Patients With Untreated Early Arthritis , 2018, Arthritis & rheumatology.
[20] J. Hsu,et al. CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma , 2018, Haematologica.
[21] A. Krawczyk,et al. Role of L-Particles during Herpes Simplex Virus Infection , 2017, Front. Microbiol..
[22] Peng Li,et al. NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis , 2017, Scientific Reports.
[23] D. Fuchs,et al. Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation , 2017, Front. Immunol..
[24] P. Höllsberg,et al. Expression of soluble CD83 in plasma from early‐stage rheumatoid arthritis patients is not modified by anti‐TNF‐&agr; therapy , 2017, Cytokine.
[25] G. Schett,et al. Pathogenetic insights from the treatment of rheumatoid arthritis , 2017, The Lancet.
[26] M. Zygmunt,et al. A Kinetic Study of CD83 Reveals an Upregulation and Higher Production of sCD83 in Lymphocytes from Pregnant Mice , 2017, Front. Immunol..
[27] Y. Muller,et al. Crystal Structure of the Extracellular Domain of the Human Dendritic Cell Surface Marker CD83. , 2017, Journal of Molecular Biology.
[28] M. Debenedette,et al. Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4/MD-2 Complex on CD14+ Monocytes , 2017, The Journal of Immunology.
[29] A. Steinkasserer,et al. The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells , 2017, Front. Microbiol..
[30] J. Hsu,et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population , 2016, The Journal of Immunology.
[31] H. Ploegh,et al. Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83 , 2016, The Journal of experimental medicine.
[32] A. Rudensky,et al. An essential role for IL-2 receptor in regulatory T cell function , 2016, Nature Immunology.
[33] T. Winkler,et al. CD83 Modulates B Cell Activation and Germinal Center Responses , 2016, The Journal of Immunology.
[34] C. Daniel,et al. L Particles Transmit Viral Proteins from Herpes Simplex Virus 1-Infected Mature Dendritic Cells to Uninfected Bystander Cells, Inducing CD83 Downmodulation , 2015, Journal of Virology.
[35] Yuetsu Tanaka,et al. Human T-cell leukemia virus type-I Tax induces the expression of CD83 on T cells , 2015, Retrovirology.
[36] Qiang Zhou,et al. Continuous expression of CD83 on activated human CD4+ T cells is correlated with their differentiation into induced regulatory T cells , 2015, Molecular medicine reports.
[37] M. Raftery,et al. Dendritic cells as Achilles’ heel and Trojan horse during varicella zoster virus infection , 2015, Front. Microbiol..
[38] A. Steinkasserer,et al. CD83 and GRASP55 interact in human dendritic cells. , 2015, Biochemical and biophysical research communications.
[39] A. Steinkasserer,et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. , 2015, Immunobiology.
[40] T. Malek,et al. IL-2Rβ–Dependent Signaling and CD103 Functionally Cooperate To Maintain Tolerance in the Gut Mucosa , 2015, The Journal of Immunology.
[41] María Martín,et al. UniProt: A hub for protein information , 2015 .
[42] The Uniprot Consortium,et al. UniProt: a hub for protein information , 2014, Nucleic Acids Res..
[43] S. Ho,et al. Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis , 2014, Mucosal Immunology.
[44] A. Steinkasserer,et al. Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function. , 2014, The Journal of general virology.
[45] A. Zenclussen,et al. B Cells: The Old New Players in Reproductive Immunology , 2014, Front. Immunol..
[46] J. Barbuto,et al. Dendritic cell membrane CD83 enhances immune responses by boosting intracellular calcium release in T lymphocytes , 2014, Journal of leukocyte biology.
[47] Yugang Guo,et al. The Expression and Characterization of Functionally Active Soluble CD83 by Pichia pastoris Using High-Density Fermentation , 2014, PloS one.
[48] A. Pommer,et al. Soluble CD83 ameliorates experimental colitis in mice , 2014, Mucosal Immunology.
[49] A. Steinkasserer,et al. Soluble human CD83 ameliorates lupus in NZB/W F1 mice. , 2013, Immunobiology.
[50] L. Boon,et al. Topical Application of Soluble CD83 Induces IDO-Mediated Immune Modulation, Increases Foxp3+ T Cells, and Prolongs Allogeneic Corneal Graft Survival , 2013, The Journal of Immunology.
[51] T. Winkler,et al. Multiple Interferon Regulatory Factor and NF-κB Sites Cooperate in Mediating Cell-Type- and Maturation-Specific Activation of the Human CD83 Promoter in Dendritic Cells , 2013, Molecular and Cellular Biology.
[52] T. Malek,et al. IL-2R Signaling Is Essential for Functional Maturation of Regulatory T Cells during Thymic Development , 2013, The Journal of Immunology.
[53] J. Hauber,et al. Post-transcriptional regulation of CD83 expression by AUF1 proteins , 2012, Nucleic acids research.
[54] M. Stefanidou,et al. Herpes Simplex Virus 2 (HSV-2) Prevents Dendritic Cell Maturation, Induces Apoptosis, and Triggers Release of Proinflammatory Cytokines: Potential Links to HSV-HIV Synergy , 2012, Journal of Virology.
[55] Ling Wang,et al. Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Monocytes Downregulates Expression of Adaptive Immune Response Costimulatory Receptors and Proinflammatory Cytokines , 2012, Journal of Virology.
[56] Xue-guang Zhang,et al. CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2 , 2011, Proceedings of the National Academy of Sciences.
[57] B. Fleischer,et al. Activated T cells induce rapid CD83 expression on B cells by engagement of CD40. , 2011, Immunology letters.
[58] C. Goodnow,et al. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10–driven MARCH1-mediated ubiquitination and degradation , 2011, The Journal of experimental medicine.
[59] Hao Wang,et al. Prevention of Chronic Renal Allograft Rejection by Soluble CD83 , 2010, Transplantation.
[60] M. Debenedette,et al. Induction of Kidney Allograft Tolerance by Soluble CD83 Associated With Prevalence of Tolerogenic Dendritic Cells and Indoleamine 2,3-Dioxygenase , 2010, Transplantation.
[61] A. Steinkasserer,et al. Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection , 2010, Transplantation.
[62] S. Ishido,et al. MARCH-I: A new regulator of dendritic cell function , 2010, Molecules and cells.
[63] O. Ohara,et al. Cutting Edge: Requirement of MARCH-I-Mediated MHC II Ubiquitination for the Maintenance of Conventional Dendritic Cells1 , 2009, The Journal of Immunology.
[64] Q. Pittman,et al. Early Life Exposure to Lipopolysaccharide Suppresses Experimental Autoimmune Encephalomyelitis by Promoting Tolerogenic Dendritic Cells and Regulatory T Cells1 , 2009, The Journal of Immunology.
[65] Liwu Li,et al. Differential Regulation of Foxp3 and IL-17 Expression in CD4 T Helper Cells by IRAK-11 , 2009, The Journal of Immunology.
[66] B. Fleischer,et al. Engagement of CD83 on B Cells Modulates B Cell Function In Vivo1 , 2009, The Journal of Immunology.
[67] J. Hauber,et al. Phosphorylation of the HuR ligand APRIL by casein kinase 2 regulates CD83 expression , 2009, European journal of immunology.
[68] B. Fleischer,et al. CD83 on murine APC does not function as a costimulatory receptor for T cells. , 2008, Immunology letters.
[69] T. Mak,et al. The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo , 2008, Proceedings of the National Academy of Sciences.
[70] W. Stoorvogel,et al. Endosomal sorting of MHC class II determines antigen presentation by dendritic cells. , 2008, Current opinion in cell biology.
[71] Lingyun Sun,et al. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression , 2008, Lupus.
[72] M. Probst-Kepper,et al. CD83 Expression in CD4+ T Cells Modulates Inflammation and Autoimmunity1 , 2008, The Journal of Immunology.
[73] Nadia Catalan,et al. MHC class II stabilization at the surface of human dendritic cells is the result of maturation-dependent MARCH I down-regulation , 2008, Proceedings of the National Academy of Sciences.
[74] John P. Moore,et al. HIV-1 gp120 Mannoses Induce Immunosuppressive Responses from Dendritic Cells , 2007, PLoS pathogens.
[75] D. Maskell,et al. Unique Features and Distribution of the Chicken CD83+ Cell1 , 2007, The Journal of Immunology.
[76] M. Fujimoto,et al. CD83 Expression Is a Sensitive Marker of Activation Required for B Cell and CD4+ T Cell Longevity In Vivo1 , 2007, The Journal of Immunology.
[77] R. Watanabe,et al. CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. , 2007, International immunology.
[78] A. Steinkasserer,et al. Soluble CD14 and CD83 from Human Neonatal Antigen-Presenting Cells Are Inducible by Commensal Bacteria and Suppress Allergen-Induced Human Neonatal Th2 Differentiation , 2007, Infection and Immunity.
[79] A. Steinkasserer,et al. CD83 Knockdown in Monocyte-Derived Dendritic Cells by Small Interfering RNA Leads to a Diminished T Cell Stimulation1 , 2007, The Journal of Immunology.
[80] C. Boutell,et al. Herpes Simplex Virus Type 1 Induces CD83 Degradation in Mature Dendritic Cells with Immediate-Early Kinetics via the Cellular Proteasome , 2007, Journal of Virology.
[81] A. Steinkasserer,et al. CD83: an update on functions and prospects of the maturation marker of dendritic cells , 2007, Archives of Dermatological Research.
[82] S. Fillatreau,et al. CD83 is a regulator of murine B cell function in vivo , 2007, European journal of immunology.
[83] P. Xiong,et al. A limited course of soluble CD83 delays acute cellular rejection of MHC‐mismatched mouse skin allografts , 2007, Transplant international : official journal of the European Society for Organ Transplantation.
[84] J. Aerts,et al. CD83 expression on dendritic cells and T cells: Correlation with effective immune responses , 2007, European journal of immunology.
[85] F. Belardelli,et al. The biology of dendritic cells and HIV infection , 2007 .
[86] D. Neuberg,et al. Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. , 2006, Blood.
[87] A. Steinkasserer,et al. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients. , 2006, Tissue antigens.
[88] C. Rinaldo,et al. Human Immunodeficiency Virus Type 1 Vpr Impairs Dendritic Cell Maturation and T-Cell Activation: Implications for Viral Immune Escape , 2005, Journal of Virology.
[89] Heinrich Sticht,et al. CD83 is a dimer: Comparative analysis of monomeric and dimeric isoforms. , 2005, Biochemical and biophysical research communications.
[90] T. Bieber,et al. CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. , 2005, International immunology.
[91] D. Weiner,et al. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. , 2004, International immunology.
[92] W. Cao,et al. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. , 2005, The Biochemical journal.
[93] F. Belardelli,et al. Human Immunodeficiency Virus Type 1 gp120 Induces Abnormal Maturation and Functional Alterations of Dendritic Cells: a Novel Mechanism for AIDS Pathogenesis , 2004, Journal of Virology.
[94] S. Proll,et al. A Novel Mutation in CD83 Results in the Development of a Unique Population of CD4+ T Cells , 2004, The Journal of Immunology.
[95] A. Steinkasserer,et al. Prevention and Treatment of Experimental Autoimmune Encephalomyelitis by Soluble CD83 , 2004, The Journal of experimental medicine.
[96] James W. Young,et al. Infection of mature monocyte-derived dendritic cells with human cytomegalovirus inhibits stimulation of T-cell proliferation via the release of soluble CD83. , 2004, Blood.
[97] Christine Trumpfheller,et al. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[98] P. Stone,et al. CD83(+)dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. , 2004, Placenta.
[99] B. Fleischer,et al. Enhanced Activation of CD83‐Positive T Cells * , 2003, Scandinavian journal of immunology.
[100] Wolfgang Hammerschmidt,et al. Latent Membrane Protein 1 of Epstein-Barr Virus Induces CD83 by the NF-κB Signaling Pathway , 2003, Journal of Virology.
[101] A. Cunningham,et al. Varicella-Zoster Virus Productively Infects Mature Dendritic Cells and Alters Their Immune Function , 2003, Journal of Virology.
[102] K. Andrassy,et al. Up‐regulation of the dendritic cell marker CD83 on polymorphonuclear neutrophils (PMN): divergent expression in acute bacterial infections and chronic inflammatory disease , 2002, Clinical and experimental immunology.
[103] A. Mehl,et al. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. , 2002, Blood.
[104] M. Fujimoto,et al. CD83 Expression Influences CD4+ T Cell Development in the Thymus , 2002, Cell.
[105] G. Schuler,et al. Cloning and characterization of the promoter region of the human CD83 gene. , 2002, Immunobiology.
[106] E. Kremmer,et al. The Extracellular Domain of CD83 Inhibits Dendritic Cell–mediated T Cell Stimulation and Binds to a Ligand on Dendritic Cells , 2001, The Journal of experimental medicine.
[107] M. Grisham,et al. Immunological Basis of Inflammatory Bowel Disease: Role of the Microcirculation , 2001, Microcirculation.
[108] B. Hock,et al. A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera. , 2001, International immunology.
[109] J. Ledbetter,et al. CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8+ T Cells1 , 2001, The Journal of Immunology.
[110] J. Ledbetter,et al. CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected]. , 2001, Journal of immunology.
[111] B. Fleischer,et al. Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. , 2000, International immunology.
[112] D. Nixon,et al. Requirement of Mature Dendritic Cells for Efficient Activation of Influenza A-Specific Memory CD8+ T Cells1 , 2000, The Journal of Immunology.
[113] J. Hauber,et al. Inhibition of Cd83 Cell Surface Expression during Dendritic Cell Maturation by Interference with Nuclear Export of Cd83 mRNA , 2000, The Journal of experimental medicine.
[114] R. Steinman,et al. Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. , 1999, Journal of immunology.
[115] G. Schuler,et al. Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation , 1999, FEBS letters.
[116] A. Lanzavecchia,et al. Inhibition of dendritic cell maturation by herpes simplex virus , 1999, European journal of immunology.
[117] D. Sheer,et al. The human dendritic cell marker CD83 maps to chromosome 6p23 , 1999, Annals of human genetics.
[118] C. Disteche,et al. The mouse Cd83 gene: structure, domain organization, and chromosome localization , 1998, Immunogenetics.
[119] O. Majdic,et al. Neutrophil Granulocyte–committed Cells Can Be Driven to Acquire Dendritic Cell Characteristics , 1998, The Journal of experimental medicine.
[120] Liangji Zhou,et al. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[121] Liangji Zhou,et al. A distinct pattern of cytokine gene expression by human CD83+ blood dendritic cells. , 1995, Blood.
[122] Liangji Zhou,et al. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. , 1995, Journal of immunology.
[123] T. Tedder,et al. New CD from the B cell section of the Fifth International Workshop on Human Leukocyte Differentiation Antigens. , 1994, Leukemia & lymphoma.
[124] C. Fox,et al. Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes , 1993 .
[125] Liangji Zhou,et al. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. , 1992, Journal of immunology.
[126] E. B. Wilson,et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES. , 1916, Science.